<table border="single" frame="box" id="ID_D3A835DB-7AEE-41E4-B59B-CB80A39B6333" width="387" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption id="ID_87816508-582D-42E8-A8B3-C32CD60710DC">Table 1. Mean (CV%)† Pharmacokinetic Parameters of Etodolac in Normal Healthy Adults and Various Special Populations</caption>
<col width="11.628%"></col>
<col width="9.302%"></col>
<col width="9.302%"></col>
<col width="11.628%"></col>
<col width="13.953%"></col>
<col width="11.628%"></col>
<col width="11.628%"></col>
<col width="9.302%"></col>
<col width="11.628%"></col>
<tfoot id="ID_7263BC45-B182-4996-8CCD-AD4CBD1F868B">
<tr><td colspan="9">†% Coefficient of variation<br/>*Age Range (years)<br/>NA = not available</td></tr>
</tfoot>
<tbody>
<tr id="ID_ABC257A7-25A1-40D6-8D2A-84A83D16A898"><td align="left" rowspan="2" valign="top"><paragraph>PK</paragraph>Parameters</td><td align="left" rowspan="2" valign="top"><paragraph>Normal</paragraph><paragraph>Healthy</paragraph><paragraph>Adults</paragraph><paragraph>(18-65)*</paragraph>(n=179)</td><td align="left" rowspan="2" valign="top"><paragraph>Healthy</paragraph><paragraph>Males</paragraph><paragraph>(18-65)</paragraph>(n=176)</td><td align="left" rowspan="2" valign="top">
<paragraph>Healthy</paragraph>
<paragraph>Females</paragraph>
<paragraph>(27-65)</paragraph>
<paragraph>(n=3)</paragraph>
</td><td align="left" rowspan="2" valign="top">
<paragraph>Elderly</paragraph>
<paragraph>(&gt;65)</paragraph>
<paragraph>(70-84)</paragraph>
</td><td align="left" colspan="2" valign="top"><paragraph>Hemodialysis</paragraph><paragraph>(24-65)</paragraph>(n=9)</td><td align="left" rowspan="2" valign="top"><paragraph>Renal</paragraph><paragraph>Impairment</paragraph><paragraph>(46-73)</paragraph>(n=10)</td><td align="left" rowspan="2" valign="top">
<paragraph>Hepatic</paragraph>
<paragraph>Impairment</paragraph>
<paragraph>(34-60)</paragraph>
<paragraph>(n=9)</paragraph>
</td></tr>
<tr id="ID_952ABF92-78CA-4224-9D06-072D65DA9083"><td align="left" valign="top"><paragraph>Dialysis</paragraph>On</td><td align="left" valign="top">
<paragraph>Dialysis</paragraph>
<paragraph>Off</paragraph>
</td></tr>
<tr id="ID_7DD0F668-CF09-4878-B99D-E8166AC7987B"><td align="left" valign="top">Tmax, h</td><td align="left" valign="top"><paragraph>1.4</paragraph>(61%)†</td><td align="left" valign="top"><paragraph>1.4</paragraph>(60%)</td><td align="left" valign="top"><paragraph>1.7</paragraph>(60%)</td><td align="left" valign="top"><paragraph>1.2</paragraph>(43%)</td><td align="left" valign="top"><paragraph>1.7</paragraph>(88%)</td><td align="left" valign="top"><paragraph>0.9</paragraph>(67%)</td><td align="left" valign="top"><paragraph>2.1</paragraph>(46%)</td><td align="left" valign="top"><paragraph>1.1</paragraph>(15%)</td></tr>
<tr id="ID_0F29B4C6-2C92-4C4B-8CD3-94B986E9DF04"><td align="left" valign="top"><paragraph>Oral</paragraph><paragraph>Clearance,</paragraph><paragraph>mL/h/kg</paragraph>(CL/F)</td><td align="left" valign="top"><paragraph>49.1</paragraph>(33%)</td><td align="left" valign="top"><paragraph>49.4</paragraph>(33%)</td><td align="left" valign="top"><paragraph>35.7</paragraph>(28%)</td><td align="left" valign="top"><paragraph>45.7</paragraph>(27%)</td><td align="left" valign="top">NA</td><td align="left" valign="top">NA</td><td align="left" valign="top"><paragraph>58.3</paragraph>(19%)</td><td align="left" valign="top"><paragraph>42.0</paragraph>(43%)</td></tr>
<tr id="ID_2BBBA184-A349-4553-ACA1-A0CE53C2DE5A"><td align="left" valign="top"><paragraph>Apparent</paragraph><paragraph>Volume of</paragraph><paragraph>Distribution,</paragraph>mL/kg (Vd/F)</td><td align="left" valign="top"><paragraph>393</paragraph>(29%)</td><td align="left" valign="top"><paragraph>394</paragraph>(29%)</td><td align="left" valign="top"><paragraph>300</paragraph>(8%)</td><td align="left" valign="top"><paragraph>414</paragraph>(38%)</td><td align="left" valign="top">NA</td><td align="left" valign="top">NA</td><td align="left" valign="top">NA</td><td align="left" valign="top">NA</td></tr>
<tr id="ID_B351E52E-B036-4687-8FCB-7C0FF422CB91"><td align="left" valign="top"><paragraph>Terminal</paragraph>Half-Life, h</td><td align="left" valign="top"><paragraph>6.4</paragraph>(22%)</td><td align="left" valign="top"><paragraph>6.4</paragraph>(22%)</td><td align="left" valign="top"><paragraph>7.9</paragraph>(35%)</td><td align="left" valign="top"><paragraph>6.5</paragraph>(24%)</td><td align="left" valign="top"><paragraph>5.1</paragraph>(22%)</td><td align="left" valign="top"><paragraph>7.5</paragraph>(34%)</td><td align="left" valign="top">NA</td><td align="left" valign="top"><paragraph>5.7</paragraph>(24%)</td></tr>
</tbody>
</table>